Critical Bone Defect Affecting the Outcome of Management in Anatomical Type IV Chronic Osteomyelitis
Open Access
- 6 May 2024
- journal article
- research article
- Published by Jaypee Brothers Medical Publishing in Strategies in Trauma and Limb Reconstruction
- Vol. 19 (1) , 26-31
Abstract
The Cierny and Mader classification assists with decision-making by stratifying host status and the pathoanatomy of the disease. However, the anatomical type IV represents a heterogenous group with regard to treatment requirements and outcomes. We propose that modification of the Cierny and Mader anatomical classification with an additional type V classifier (diffuse corticomedullary involvement with an associated critical bone defect) will allow more accurate stratification of patients and tailoring of treatment strategies. A retrospective review of 83 patients undergoing treatment for Cierny and Mader anatomical type IV osteomyelitis of the appendicular skeleton at a single centre was performed. Risk factors for the presence of a critical bone defect were female patients [OR 3.1 (95% CI, 1.08–8.92)] and requirement for soft tissue reconstruction [OR 3.35 (95% CI, 1.35–8.31)]; osteomyelitis of the femur was negatively associated with the presence of a critical bone defect [OR 0.13 (95% CI, 0.03–0.66)]. There was no statistically significant risk of adverse outcomes (failure to eradicate infection or achieve bone union) associated with the presence of a critical-sized bone defect. The median time to the bone union was ten months (95% CI, 7.9–12.1 months). There was a statistically significant difference in the median time to bone union between cases with a critical bone defect [12.0 months (95% CI, 10.2–13.7 months)] and those without [6.0 months (95% CI, 4.8–7.1 months)]. This study provided evidence to support the introduction of a new subgroup of the Cierny and Mader anatomical classification (Type V). Using a standardised approach to management, comparable early outcomes can be achieved in patients with Cierny and Mader anatomical type V osteomyelitis. However, to achieve a successful outcome, there is a requirement for additional bone and soft tissue reconstruction procedures with an associated increase in treatment time. Tsang STJ, Epstein GZ, Ferreira N. Critical Bone Defect Affecting the Outcome of Management in Anatomical Type IV Chronic Osteomyelitis. Strategies Trauma Limb Reconstr 2024;19(1):26–31.Keywords
This publication has 19 references indexed in Scilit:
- Management of critical-sized bone defects in the treatment of fracture-related infection: a systematic review and pooled analysisArchives of orthopaedic and trauma surgery, 2020
- Health Care Costs of Post-traumatic Osteomyelitis in China: Current Situation and Influencing FactorsJournal of Surgical Research, 2020
- Comparison of Ilizarov Bifocal, Acute Shortening and Relengthening with Bone Transport in the Treatment of Infected, Segmental Defects of the TibiaJournal of Clinical Medicine, 2020
- Treatment of critical-sized bone defects: clinical and tissue engineering perspectivesEuropean Journal of Orthopaedic Surgery & Traumatology, 2017
- Two stage management of Cierny-Mader type IV chronic osteomyelitis of the long bonesInjury, 2017
- A modified staging system for chronic osteomyelitisJournal of Orthopaedics, 2015
- Critical-Sized Defect in the TibiaJournal of Orthopaedic Trauma, 2014
- Bone transport techniques in posttraumatic bone defectsOrthopaedics & Traumatology: Surgery & Research, 2012
- Treatment of posttraumatic bone defects by the induced membrane techniqueOrthopaedics & Traumatology: Surgery & Research, 2012
- The management of fractures with bone lossThe Journal of Bone and Joint Surgery. British volume, 2005